Leading pharmaceutical firms fail to finalize business plan

With a gloomy prospect that Korea's key industries are expected to suffer from a full-fledged global economic downturn this year as a result of the international financial market meltdown, major pharmaceutical companies may have to delay its business-related decisions.

Industry observers say their business plan - which usually takes place in December - may be postponed for a couple of months...